BiotechTube

Bimatoprost Implant System (High Dose) + Bimatoprost Implant System (Low Dose) + Timolol Maleate Ophthalmic Solution, 0.5%

Phase 1/2Active
0 watching 0 views this week💤 Quiet
36
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Cataract

Conditions

Cataract, Glaucoma, Ocular Hypertension

Trial Timeline

Oct 13, 2023 → Nov 1, 2027

NCT ID
NCT06120842

About Bimatoprost Implant System (High Dose) + Bimatoprost Implant System (Low Dose) + Timolol Maleate Ophthalmic Solution, 0.5%

Bimatoprost Implant System (High Dose) + Bimatoprost Implant System (Low Dose) + Timolol Maleate Ophthalmic Solution, 0.5% is a phase 1/2 stage product being developed by SpyGlass Pharma for Cataract. The current trial status is active. This product is registered under clinical trial identifier NCT06120842. Target conditions include Cataract, Glaucoma, Ocular Hypertension.

Hype Score Breakdown

Clinical
13
Activity
8
Company
5
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT06120842Phase 1/2Active

Competing Products

20 competing products in Cataract

See all competitors
ProductCompanyStageHype Score
ISV-305Sun PharmaceuticalPhase 3
77
ISV-303 + Bromday™Sun PharmaceuticalPhase 2
52
ISV-305Sun PharmaceuticalPhase 3
77
DE-108 + Levofloxacin 0.5%Santen PharmaceuticalPhase 3
77
Prednisolone acetateNovartisApproved
85
Omidria + Dextenza (dexamethasone ophthalmic insert) 0.4mg + Dexycu, 9% Intraocular Suspension + Prednisolone Acetate 1%Ocular TherapeutixApproved
80
Dextenza 0.4Mg Ophthalmic InsertOcular TherapeutixApproved
80
Dextenza Ophthalmic Insert + Prednisolone acetate ophthalmic suspension USP 1%Ocular TherapeutixPhase 3
72
Dextenza 0.4Mg Ophthalmic Insert + Prednisolone Acetate 1% Ophthalmic Suspension [PRED FORTE]Ocular TherapeutixPhase 2/3
60
Dexamethasone 0.4 MG [Dextenza]Ocular TherapeutixApproved
80
Dextenza 0.4Mg Ophthalmic Insert + Topical prednisolone acetateOcular TherapeutixApproved
80
Dextenza 0.4mg intracanalicular Insert + Durezol 0.05% Ophthalmic EmulsionOcular TherapeutixApproved
80
DexycuEyePoint PharmaceuticalsPhase 3
72
Dexycu + Standard of Care post operative eye drops (steroid, antibiotic, NSAID)EyePoint PharmaceuticalsApproved
80
DexycuEyePoint PharmaceuticalsPhase 3
72
DEXYCU (dexamethasone intraocular suspension) 9%.EyePoint PharmaceuticalsPre-clinical
18
Dexamethasone + Prednisolone Acetate OphthalmicEyePoint PharmaceuticalsApproved
80
Bimatoprost Implant System + Timolol Maleate Ophthalmic Solution, 0.5%SpyGlass PharmaPhase 3
72
Bimatoprost Implant System + Timolol Maleate Ophthalmic Solution, 0.5%SpyGlass PharmaPhase 3
72
OMS302 + OMS302-PE + VehicleOmeros CorporationPhase 1/2
36

Other Products from SpyGlass Pharma

Bimatoprost Implant System + Timolol Maleate Ophthalmic Solution, 0.5%Phase 3
72
Bimatoprost Implant System + Timolol Maleate Ophthalmic Solution, 0.5%Phase 3
72